EXODYA: Effect of Exercise and Omega-3 on Metabolic Health in Elderly

Sponsor
Charles University, Czech Republic (Other)
Overall Status
Completed
CT.gov ID
NCT03386461
Collaborator
(none)
55
1
2
35.8
1.5

Study Details

Study Description

Brief Summary

The aim of this project is to investigate in elderly women, the effect of combined aerobic and resistive training and concomitant supplementation with omega-3 fatty acids on adipogenesis, metabolic functions and pro-inflammatory status of adipose tissue and on systemic metabolic profile.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise training
  • Dietary Supplement: omega 3 supplementation
  • Dietary Supplement: placebo
N/A

Detailed Description

Aging is associated with development of disturbances of lipid and carbohydrate metabolism and with systemic pro-inflammatory state similarly to the alterations observed in obese individuals. Metabolic and immune dysfunction of adipose tissue has been suggested as an important contributing trigger to this condition. EXODYA project is a clinical study in elderly individuals that aims to establish benefits of lifestyle intervention and nutritional supplementation -either alone or in combination- for the amelioration of systemic and adipose tissue metabolic and immune disturbances. Effects of 4 months´ intervention with combined aerobic plus resistive exercise training and supplementation with omega-3 polyunsaturated fatty acids on systemic metabolic profile and molecular characteristics of adipose tissue will be investigated in elderly women. Thus, a proof-of-concept will be provided for novel recommendations and guidelines for lifestyle interventions in elderly population

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The exercise training intervention with or without omega-3 supplementation (Calanus oil) will be prescribed to non-trained sedentary elderly womenThe exercise training intervention with or without omega-3 supplementation (Calanus oil) will be prescribed to non-trained sedentary elderly women
Masking:
Double (Participant, Care Provider)
Masking Description:
Two types of pills (calanus or placebo) will be prescribed to subjects, investigator will randomly assign the subjects to the arms
Primary Purpose:
Basic Science
Official Title:
Effect of Exercise Training and Omega-3 Fatty Acids on Metabolic Health and Dysfunction of Adipose Tissue in Elderly
Actual Study Start Date :
Jan 5, 2017
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise + Omega 3 supplementation

Subjects will be enrolled in physical activity program that consists of combined aerobic and resistive training 3 times a week for 4 months. Training will be supervised by physiotherapists experienced in exercise training of elderly (Senior Fitness, and Faculty of Physical Education and Sport). Subjects will take 5 capsules od Calanus oil (containing approx. 250 mg EPA and DHA per day).

Behavioral: Exercise training
Combined aerobic and resistive training 3 times a week for 4 months. The strength training will be performed at moderate intensity (i.e., 50-60% of RM), and moderate volume (i.e., 2 to 3 sets per exercise). Endurance training will be performed at moderate- to high-intensity (i.e., 60-85% of VO2max) in the form of continuous and interval training (for high intensities), respectively. The training intensity will be prescribed individually on the basis of the initial exercise testing. Subjects will be thoroughly instructed on effective home-based exercise and advised to exercise in total 5 days a week.

Dietary Supplement: omega 3 supplementation
Capsules with high content of omega 3 fatty acids (Calanus oil) will be taken every day with lunch meal. The content of omega-3 fatty acids (EPA, DHA) per day should reach 250 mg.
Other Names:
  • Calanus oil
  • Placebo Comparator: Exercise + placebo

    Subjects will be enrolled in physical activity program that consists of combined aerobic and resistive training 3 times a week for 4 months. Training will be supervised by physiotherapists experienced in exercise training of elderly. Subjects will take 5 capsules od placebo per day (provided by Calanus oil company, containing sunflower oil).

    Behavioral: Exercise training
    Combined aerobic and resistive training 3 times a week for 4 months. The strength training will be performed at moderate intensity (i.e., 50-60% of RM), and moderate volume (i.e., 2 to 3 sets per exercise). Endurance training will be performed at moderate- to high-intensity (i.e., 60-85% of VO2max) in the form of continuous and interval training (for high intensities), respectively. The training intensity will be prescribed individually on the basis of the initial exercise testing. Subjects will be thoroughly instructed on effective home-based exercise and advised to exercise in total 5 days a week.

    Dietary Supplement: placebo
    Capsules with content of omega 6 fatty acids (sunflower oil) will be taken every day with lunch meal.
    Other Names:
  • sunflower oil
  • Outcome Measures

    Primary Outcome Measures

    1. Change in adipose tissue inflammation [through study completion, an average of 1 year]

      analysis of distribution of immune cells (flow cytometry analysis)

    2. Change in adipose tissue inflammatory signalling [through study completion, an average of 1 year]

      analysis of pro-resolving mediators (UPLC-MS/MS methodology)

    Secondary Outcome Measures

    1. Change in insulin sensitivity [through study completion, an average of 1 year]

      Hyperinsulinemic izoglycemic clamp (GDR-glucose disposal rate)

    2. Change in physical performance [through study completion, an average of 1 year]

      Maximum graded exercise test on bicycle ergometer (Vo2max)

    3. Change in gene expression in adipose tissue [through study completion, an average of 1 year]

      mRNA expression of metabolic and inflammatory genes in adipose tissue

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years to 80 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • elderly women: age 60-80

    • non-trained (without regular physical activity)

    • BMI in the range of 25-30 kg/m2

    Exclusion Criteria:
    • diagnosed cancer, diabetes, liver and renal diseases, untreated hyper- or hypo-thyroidism, long term use of anti-inflammatory medication (anti-rheumatics and analgesics affecting cyclooxygenases (100 mg of anopyrin daily is acceptable), steroids and/or Omega-3 dietary supplements

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Third Faculty of Medicine, Charles University Prague Czechia 100 00

    Sponsors and Collaborators

    • Charles University, Czech Republic

    Investigators

    • Principal Investigator: Michaela Siklova, PhD, Third faculty of medicine, Charles University in Prague

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Michaela Siklova, Principal Investigator, Charles University, Czech Republic
    ClinicalTrials.gov Identifier:
    NCT03386461
    Other Study ID Numbers:
    • AZV 16-29182A
    First Posted:
    Dec 29, 2017
    Last Update Posted:
    Feb 17, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Michaela Siklova, Principal Investigator, Charles University, Czech Republic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 17, 2020